Literature DB >> 7862678

Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus.

D L Rothman1, I Magnusson, G Cline, D Gerard, C R Kahn, R G Shulman, G I Shulman.   

Abstract

Recent studies have demonstrated that reduced insulin-stimulated muscle glycogen synthesis is the major cause of insulin resistance in patients with non-insulin-dependent diabetes mellitus (NIDDM). This reduced rate has been assigned to a defect in either glucose transport or hexokinase activity. However it is unknown whether this is a primary or acquired defect in the pathogenesis of NIDDM. To examine this question, we measured the rate of muscle glycogen synthesis and the muscle glucose 6-phosphate (G6P) concentration using 13C and 31P NMR spectroscopy as well as oxidative and nonoxidative glucose metabolism in six lean, normoglycemic offspring of parents with NIDDM and seven age/weight-matched control subjects under hyperglycemic (approximately 11 mM)-hyperinsulinemic (approximately 480 pM) clamp conditions. The offspring of parents with NIDDM had a 50% reduction in total glucose metabolism, primarily due to a decrease in the nonoxidative component. The rate of muscle glycogen synthesis was reduced by 70% (P < 0.005) and muscle G6P concentration was reduced by 40% (P < 0.003), which suggests impaired muscle glucose transport/hexokinase activity. These changes were similar to those previously observed in subjects with fully developed NIDDM. When the control subjects were studied at similar insulin levels (approximately 440 pM) but euglycemic plasma glucose concentration (approximately 5 mM), both the rate of glycogen synthesis and the G6P concentration were reduced to values similar to the offspring of parents with NIDDM. We conclude that insulin-resistant offspring of parents with NIDDM have reduced nonoxidative glucose metabolism and muscle glycogen synthesis secondary to a defect in muscle glucose transport/hexokinase activity prior to the onset of overt hyperglycemia. The presence of this defect in these subjects suggests that it may be the primary factor in the pathogenesis of NIDDM.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7862678      PMCID: PMC42621          DOI: 10.1073/pnas.92.4.983

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Cloning and characterization of the major insulin-responsive glucose transporter expressed in human skeletal muscle and other insulin-responsive tissues.

Authors:  H Fukumoto; T Kayano; J B Buse; Y Edwards; P F Pilch; G I Bell; S Seino
Journal:  J Biol Chem       Date:  1989-05-15       Impact factor: 5.157

2.  Role of glucose transporters in the cellular insulin resistance of type II non-insulin-dependent diabetes mellitus.

Authors:  W T Garvey; T P Huecksteadt; S Matthaei; J M Olefsky
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

3.  Kinetics of glucose disposal in whole body and across the forearm in man.

Authors:  H Yki-Järvinen; A A Young; C Lamkin; J E Foley
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

4.  In vitro autoregulation of glucose utilization in rat soleus muscle.

Authors:  S Sasson; D Edelson; E Cerasi
Journal:  Diabetes       Date:  1987-09       Impact factor: 9.461

5.  Regulation of glycogen synthase and phosphorylase activities by glucose and insulin in human skeletal muscle.

Authors:  H Yki-Järvinen; D Mott; A A Young; K Stone; C Bogardus
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

6.  Impaired insulin-stimulated muscle glycogen synthase activation in vivo in man is related to low fasting glycogen synthase phosphatase activity.

Authors:  D Freymond; C Bogardus; M Okubo; K Stone; D Mott
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

7.  In vivo regulation of rat muscle glycogen resynthesis after intense exercise.

Authors:  G Bloch; J R Chase; D B Meyer; M J Avison; G I Shulman; R G Shulman
Journal:  Am J Physiol       Date:  1994-01

8.  Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man.

Authors:  S Lillioja; A A Young; C L Culter; J L Ivy; W G Abbott; J K Zawadzki; H Yki-Järvinen; L Christin; T W Secomb; C Bogardus
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

9.  Insulin response of components of whole-body and muscle carbohydrate metabolism in humans.

Authors:  A A Young; C Bogardus; K Stone; D M Mott
Journal:  Am J Physiol       Date:  1988-02

10.  Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians.

Authors:  S Lillioja; D M Mott; B V Howard; P H Bennett; H Yki-Järvinen; D Freymond; B L Nyomba; F Zurlo; B Swinburn; C Bogardus
Journal:  N Engl J Med       Date:  1988-05-12       Impact factor: 91.245

View more
  72 in total

Review 1.  Cellular mechanisms of insulin resistance.

Authors:  G I Shulman
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

2.  Protein phosphorylation can regulate metabolite concentrations rather than control flux: the example of glycogen synthase.

Authors:  James R A Schafer; David A Fell; Douglas Rothman; Robert G Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-26       Impact factor: 11.205

3.  Cellular mechanism of insulin resistance in skeletal muscle.

Authors:  Kitt Falk Petersen; Gerald I Shulman
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

Review 4.  The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome.

Authors:  François R Jornayvaz; Varman T Samuel; Gerald I Shulman
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

Review 5.  Pediatric endocrine disorders of energy balance.

Authors:  Robert H Lustig
Journal:  Rev Endocr Metab Disord       Date:  2005-12       Impact factor: 6.514

Review 6.  Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction.

Authors:  Katsutaro Morino; Kitt Falk Petersen; Gerald I Shulman
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

7.  Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene.

Authors:  L Rossetti; A E Stenbit; W Chen; M Hu; N Barzilai; E B Katz; M J Charron
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

8.  Association study of genetic polymorphisms of SLC2A10 gene and type 2 diabetes in the Taiwanese population.

Authors:  W H Lin; L M Chuang; C H Chen; J I Yeh; P S Hsieh; C H Cheng; Y T Chen
Journal:  Diabetologia       Date:  2006-04-04       Impact factor: 10.122

9.  Muscle-Specific Insulin Receptor Overexpression Protects Mice From Diet-Induced Glucose Intolerance but Leads to Postreceptor Insulin Resistance.

Authors:  Guoxiao Wang; Yingying Yu; Weikang Cai; Thiago M Batista; Sujin Suk; Hye Lim Noh; Michael Hirshman; Pasquale Nigro; Mengyao Ella Li; Samir Softic; Laurie Goodyear; Jason K Kim; C Ronald Kahn
Journal:  Diabetes       Date:  2020-08-31       Impact factor: 9.461

10.  Rab5 activity regulates GLUT4 sorting into insulin-responsive and non-insulin-responsive endosomal compartments: a potential mechanism for development of insulin resistance.

Authors:  Kandice L Tessneer; Robert M Jackson; Beth A Griesel; Ann Louise Olson
Journal:  Endocrinology       Date:  2014-06-16       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.